Background Misconceptions about ADHD stigmatize affected people, reduce credibility of
providers, and prevent/delay treatment. To challenge misconceptions, we curated findings …

Introduction The term neurodiversity is defined and discussed from the perspectives of
neuroscience, psychology and campaigners with lived experience, illustrating the …

El trastorno por déficit de atención con hiperactividad (TDAH) es una alteración del
neurodesarrollo, cuyos síntomas principales son inatención, hiperactividad e impulsividad …

Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

Importance Reported increases in attention-deficit/hyperactivity disorder (ADHD) diagnoses
are accompanied by growing debate about the underlying factors. Although overdiagnosis is …

Background Attention-deficit hyperactivity disorder (ADHD) is a common paediatric
neurodevelopmental disorder with substantial effect on families and society. Alternatives to …

Psychostimulants, including amphetamines and methylphenidate, are first-line
pharmacotherapies for individuals with attention-deficit/hyperactivity disorder (ADHD). This …

Mental disorders frequently begin in childhood or adolescence. Psychotropic medications
have various indications for the treatment of mental disorders in this age group and are used …

Attention-deficit/hyperactivity disorder (ADHD) is a common and impairing disorder affecting
children, adolescents, and adults. Several treatment strategies are available that can …

Background The use of medications to treat attention deficit hyperactivity disorder (ADHD)
has increased, but the prevalence of ADHD medication use across different world regions is …